Literature DB >> 16322297

Peritumoral lymphatic vessel density and vascular endothelial growth factor C expression in early-stage squamous cell carcinoma of the uterine cervix.

Zoltan Gombos1, Xiaowei Xu, Christina S Chu, Paul J Zhang, Geza Acs.   

Abstract

PURPOSE: Lymphatic invasion and nodal metastasis plays a major role in the spread of cervical cancer; however, little is known about the mechanisms whereby tumor cells enter the lymphatic system. EXPERIMENTAL
DESIGN: We examined the intra- and peritumoral lymphatic vessel density (LVD) using D2-40 immunohistochemistry in 111 cervical squamous cell carcinomas and correlated them with vascular endothelial growth factor (VEGF)-C expression, clinicopathologic tumor features, and outcome.
RESULTS: Compared with benign cervix, intratumoral and peritumoral LVD was significantly increased (P < 0.0001). Peritumoral LVD was significantly higher than intratumoral LVD (P = 0.009). High peritumoral, but not intratumoral, LVD showed significant correlation with high tumor stage, lymphatic invasion, and nodal metastasis. VEGF-C showed increased expression at the invasive edge compared with the center of tumors (P < 0.0001) and correlated with high peritumoral LVD, lymphatic invasion, and nodal metastasis. High peritumoral LVD and VEGF-C expression at the invasive edge of tumors were associated with poor overall and recurrence-free survival in univariate analysis. In multivariate analysis, peritumoral LVD was the only independent term predictive of overall survival.
CONCLUSIONS: Our findings suggest a potential role for VEGF-C in tumor-induced lymphangiogenesis represented by high peritumoral LVD, which may be one of the mechanisms leading to lymphatic invasion and metastatic spread. High peritumoral LVD may be an independent prognostic factor in early-stage cervical cancer.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16322297     DOI: 10.1158/1078-0432.CCR-05-1238

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  38 in total

1.  Clinicopathological predictors of lymphatic metastasis in HNSCC: implications for molecular mechanisms of metastatic disease.

Authors:  Tovë M Goldson; Yimei Han; Kristen B Knight; Heidi L Weiss; Vicente A Resto
Journal:  J Exp Ther Oncol       Date:  2010

2.  Lymphatic vessel density and VEGF-C expression are significantly different among benign and malignant thyroid lesions.

Authors:  Eduardo Anselmo Garcia; Kleber Simões; Alda Wakamatsu; Rodrigo Albergaria Ressio; Venâncio Avancini Ferreira Alves; Adhemar Longatto-Filho; Roberto Souza Camargo
Journal:  Endocr Pathol       Date:  2010-06       Impact factor: 3.943

3.  LYVE-1 upregulation and lymphatic invasion correlate with adverse prognostic factors and lymph node metastasis in neuroblastoma.

Authors:  Pramila Ramani; Josiah V Dungwa; Margaret T May
Journal:  Virchows Arch       Date:  2012-01-13       Impact factor: 4.064

4.  Vascular endothelial growth factor (VEGF) pathway as a therapeutic target in gynecologic malignancies.

Authors:  Michael Frumovitz; Anil K Sood
Journal:  Gynecol Oncol       Date:  2007-03       Impact factor: 5.482

5.  Lymphatic vascular density and lymphangiogenesis during tumour progression of carcinoma ex pleomorphic adenoma.

Authors:  A B Soares; L Ponchio; P B Juliano; V C de Araújo; A Altemani
Journal:  J Clin Pathol       Date:  2006-11-01       Impact factor: 3.411

6.  Inducible Nitric Oxide Synthase and CD11b+Gr1+ Cells Impair Lymphatic Contraction of Tumor-Draining Lymphatic Vessels.

Authors:  Shan Liao; Echoe M Bouta; Linda M Morris; Dennis Jones; Rakesh K Jain; Timothy P Padera
Journal:  Lymphat Res Biol       Date:  2018-10-24       Impact factor: 2.589

7.  Effects of VEGFR-3 phosphorylation inhibitor on lymph node metastasis in an orthotopic diffuse-type gastric carcinoma model.

Authors:  M Yashiro; O Shinto; K Nakamura; M Tendo; T Matsuoka; T Matsuzaki; R Kaizaki; M Ohira; A Miwa; K Hirakawa
Journal:  Br J Cancer       Date:  2009-10-06       Impact factor: 7.640

8.  Stromal impact on tumor growth and lymphangiogenesis in human carcinoma xenografts.

Authors:  Elin Hadler-Olsen; Hilde Ljones Wetting; Oddveig Rikardsen; Sonja E Steigen; Premasany Kanapathippillai; Reidar Grénman; Jan-Olof Winberg; Gunbjørg Svineng; Lars Uhlin-Hansen
Journal:  Virchows Arch       Date:  2010-10-03       Impact factor: 4.064

9.  Lymphatic invasion revealed by multispectral imaging is common in primary melanomas and associates with prognosis.

Authors:  Xiaowei Xu; Phyllis A Gimotty; Dupont Guerry; Giorgos Karakousis; Patricia Van Belle; Haohai Liang; Katharine Montone; Terry Pasha; Michael E Ming; Geza Acs; Michael Feldman; Stephen Barth; Rachel Hammond; Rosalie Elenitsas; Paul J Zhang; David E Elder
Journal:  Hum Pathol       Date:  2008-04-28       Impact factor: 3.466

10.  Correlation of intratumoral lymphatic microvessel density, vascular endothelial growth factor C and cell proliferation in salivary gland tumors.

Authors:  Márcia Gimenes Americo; Yonara Maria Freire Soares Marques; Milagros Del Valle El Abras Ankha; Renata Falchete do Prado; Yasmin Rodarte Carvalho
Journal:  Med Mol Morphol       Date:  2016-05-26       Impact factor: 2.309

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.